Apollo Hospitals Share Price: APOLLOHOSP is a prominent player in the Healthcare sector, operating within the Medical Care Facilities industry. Listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE), Apollo Hospitals Enterprise Limited is well-recognized in the Indian stock market.
This comprehensive post will delve into APOLLOHOSP’s share price targets for 2024, 2025, 2026, and beyond, extending up to 2030. We will employ a variety of technical analysis methods to predict these long-term targets.
Using a machine learning approach, we will train our forecasted data on past performance to predict APOLLOHOSP’s share prices up to the year 2030. Over the years, Apollo Hospitals has demonstrated a range of trends, making it a significant entity in the market.
This section will explore APOLLOHOSP’s current market standing, its growth trajectory, and the potential impact of external market factors on its price performance leading up to 2030.
Apollo Hospitals Company Overview
Company Name | Apollo Hospitals Enterprise Ltd. |
Founded | 1983 |
Headquarters | Chennai, Tamil Nadu |
Industry | Healthcare |
Chairman | Prathap C. Reddy |
Stock Exchange Listing | NSE & BSE |
Official Website | apollohospitals.com |
Apollo Hospitals Fundamental Analysis
Metric | Value |
---|---|
Market Cap | ₹1,04,047.61 Cr. |
ROE | 13.81% |
ROCE | 17.20% |
P/E | 92.66 |
P/B | 12.7 |
Div. Yield | 0.22% |
Book Value | ₹569.63 |
Face Value | ₹5 |
EPS (TTM) | ₹78.10 |
52 Week High | ₹7,545.10 |
52 Week Low | ₹5,286 |
Also Read: ONGC Share Price Target
Apollo Hospitals Financials
Income Statement
(INR) | 2024 | Y/Y change |
---|---|---|
Revenue | 190.59B | 14.73% |
Operating expense | 48.62B | 15.25% |
Net income | 8.99B | 9.71% |
Net profit margin | 4.71 | -4.46% |
Earnings per share | 62.41 | 9.55% |
EBITDA | 22.12B | 15.75% |
Effective tax rate | 32.27% | — |
Balance Sheet
(INR) | 2024 | Y/Y change |
---|---|---|
Cash and short-term investments | 11.90B | 63.93% |
Total assets | 167.53B | 16.12% |
Total liabilities | 94.33B | 19.45% |
Total equity | 73.21B | — |
Shares outstanding | 143.78M | — |
Price to book | 14.97 | — |
Return on assets | 6.84% | — |
Return on capital | 9.07% | — |
Cash Flow
(INR) | 2024 | Y/Y change |
---|---|---|
Net income | 8.99B | 9.71% |
Cash from operations | 19.20B | 39.46% |
Cash from investing | -15.37B | -76.57% |
Cash from financing | -3.11B | 50.85% |
Net change in cash | 721.00M | 163.75% |
Free cash flow | 11.26B | 4,731.98% |
Also Read: SAIL Share Price Target
Apollo Hospitals Share Price Target From 2024 to 2030
Year | Target Price |
---|---|
Apollo Hospitals Share Price Target 2024 | ₹7,400 |
Apollo Hospitals Share Price Target 2025 | ₹9,170 |
Apollo Hospitals Share Price Target 2026 | ₹11,380 |
Apollo Hospitals Share Price Target 2027 | ₹14,105 |
Apollo Hospitals Share Price Target 2028 | ₹17,490 |
Apollo Hospitals Share Price Target 2029 | ₹21,685 |
Apollo Hospitals Share Price Target 2030 | ₹26,870 |
Apollo Hospitals Shareholding Pattern
- Retail & Other: 5.34%
- Promoters: 29.33%
- Foreign Institutions: 45.37%
- Mutual Funds: 12.80%
- Other Domestic Institutions: 7.15%
Also Read: NMDC Share Price Target
Apollo Hospitals Competitors/Peer Companies
- Max Healthcare
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Aster DM Healthcare
- KIMS
- Rainbow Children’s Hospital
- Jupiter Life Line Hospitals
- Healthcare Global Enterprises
- Kovai Medical Center and Hospital
Also Read: Godha Cabcon Share Price Target
To connect with us, click on any of the given social media buttons.
FAQs
-
What is the Apollo Hospitals Enterprise Target Price 2025?
9,170 INR.
-
What is the Apollo Hospitals Enterprise Target Price 2026?
11,380 INR.
-
What is the Apollo Hospitals Enterprise Target Price 2027?
14,105 INR.
-
What is the Apollo Hospitals Enterprise Target Price 2029?
21,685 INR.
-
What is the Apollo Hospitals Enterprise Target Price 2030?
26,870 INR.
Disclaimer: The information in this blog is for educational purposes only, and the targets mentioned in it are given as suggestions by market analysts. Therefore, before investing your money in any company, it is mandatory to get complete information about the company and consult your financial advisor.